Subchondral Bone as a Novel Target for Regenerative Therapy of Osteochondritis Dissecans: A Case Report

4Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background Osteochondritis dissecans (OCD) is a rare disease of unclear cause characterized by subchondral bone damage and overlying cartilage defects. The current report presents the results of subchondral bone as a novel target for implantation of peripheral blood stem cells (PBSCs) in the treatment of OCD. Case Summary A 16-year-old patient diagnosed with OCD underwent subchondral bone implantation of PBSCs. Four months later, the patient's visual analog scale scores, Western Ontario and McMaster University osteoarthritis index, and whole-organ magnetic resonance imaging score improved significantly, and regeneration of cartilage and subchondral bone was observed on magnetic resonance imaging. Conclusion This is the first case of OCD treated with subchondral bone as an implantation target of PBSCs, which highlights the importance of subchondral bone for cartilage repair. This treatment could be a potential option for articular cartilage and subchondral bone recovery in OCD.

Cite

CITATION STYLE

APA

Zhang, S. Y., Xu, H. H., Xiao, M. M., Zhang, J. J., Mao, Q., He, B. J., & Tong, P. J. (2021). Subchondral Bone as a Novel Target for Regenerative Therapy of Osteochondritis Dissecans: A Case Report. World Journal of Clinical Cases, 9(15), 3623–3630. https://doi.org/10.12998/wjcc.v9.i15.3623

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free